Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | HPGD | P15428 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | CSNK2A2 | P19784 | 3/20 | 1.00 |
| ▸ | CSNK2B | P67870 | 3/20 | 1.00 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 1.00 |
| ▸ | CSNK2A3 | Q8NEV1 | 3/20 | 1.00 |
| ▸ | APEX1 | P27695 | 2/20 | 1.00 |
| ▸ | BRCA1 | P38398 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinalizarin SCHEMBL29516323 | 1.00 | MAOA (1.00) | MAOAMAPTMEN1KMT2AHPGD | |
| Quinalizarin SCHEMBL20608650 | 1.00 | MAOA (1.00) | MAOAMAPTMEN1KMT2AHPGD | |
| Quinalizarin SCHEMBL29437816 | 1.00 | MAOA (1.00) | MAOAMAPTMEN1KMT2AHPGD | |
| SCHEMBL2772226 | 0.93 | MAPT (0.86) | MAOAMAPTMEN1KMT2AHPGD | |
| SCHEMBL6904748 | 0.91 | MAPT (0.83) | MAOAMAPTMEN1KMT2AHPGD | |
| SCHEMBL11055115 | 0.89 | MAPT (0.80) | MAOAMAPTMEN1KMT2AHPGD | |
| SCHEMBL17689250 | 0.89 | MEN1 (0.79) | MAOAMAPTMEN1KMT2AHPGD | |
| Quinalizarin SCHEMBL7869031 | 0.87 | MAPT (0.76) | MAOAMAPTMEN1KMT2AHPGD | |
| SCHEMBL20457598 | 0.86 | MAOA (0.73) | MAOAMAPTMEN1KMT2AHPGD | |
| Quinalizarin SCHEMBL9308575 | 0.86 | MAOA (0.80) | MAOAMAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240293789-A1 | Encapsulation of Functional Additives in Partially-Open Microcapsules | SAS Nanotechnologies Inc. | 2024-09-05 | — | — | US | claimed |
| US-11859047-B2 | Polycarbonate resin composition and article including the same | LG CHEM, LTD. (KR) | 2024-01-02 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| US-20230057309-A1 | Inhibitors of DREAM Complex Assembly and/or Function For Use In Repairing DNA Damage | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2023-02-23 | — | — | US | claimed |
| US-11577212-B2 | Stimuli-responsive micro-reservoirs for release of encapsulants | SAS Nanotechnologies Inc. (US) | 2023-02-14 | — | — | US | claimed |
| EP-4091611-A1 | INHIBITORS OF DREAM COMPLEX ASSEMBLY AND/OR FUNCTION FOR USE IN REPAIRING DNA DAMAGE | Schumacher, Björn (DE) | 2022-11-23 | — | — | EP | claimed |
| EP-4091610-A1 | INHIBITORS OF DREAM COMPLEX ASSEMBLY AND/OR FUNCTION FOR USE IN REPAIRING DNA DAMAGE | Schumacher, Björn (DE) | 2022-11-23 | — | — | EP | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-5032526-A | Method for the colorimetric determination of sulfonates in aqueous systems | CALGON CORPORATION (US) | 1991-07-16 | — | — | US | claimed |
| US-4894346-A | Method for the colorimetric determination of polycarboxylates in aqueous systems | CALGON CORPORATION (US) | 1990-01-16 | — | — | US | claimed |
| EP-0348509-A1 | ANTI-RETROVIRAL DRUG | TSUMURA & CO. (JP) | 1990-01-03 | — | — | EP | claimed |
| EP-0144130-B1 | METHOD FOR THE COLORIMETRIC DETERMINATION OF POLYGARBOXYLATES AND SULPHONATES INAQUEOUS SYSTEMS | CALGON CORPORATION (US) | 1989-03-01 | — | — | EP | claimed |
| US-4769228-A | Method of reducing sulfur deposition in hydrogen sulfide equipment | CHEVRON RESEARCH COMPANY (US) | 1988-09-06 | — | — | US | claimed |
| US-4602913-A | Use of hydroxyanthraquinones for the coloration of human keratin fibres | L'OREAL (FR) | 1986-07-29 | — | — | US | claimed |
| US-H72-H | Organic substitutes for charcoal in black powder | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1986-06-03 | — | — | US | claimed |
| US-4529707-A | Detection of boron impurities in chlorosilanes | GENERAL ELECTRIC COMPANY (US) | 1985-07-16 | — | — | US | claimed |
| EP-0144130-A1 | Method for the colorimetric determination of polygarboxylates and sulphonates inaqueous systems | CALGON CORPORATION (US) | 1985-06-12 | — | — | EP | claimed |
| US-3992311-A | Reactive developer for electrophotography | METCALFE KENNETH A | 1976-11-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | MAOA 3718/4885MAPT 3926/4885MEN1 1711/4885 |
| US-11577212-B2 | Stimuli-responsive micro-reservoirs for release of encapsulants | ORAI1, CD44, VAPA | MAOA 147/4885MAPT 3648/4885MEN1 1542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.